JP2011139704A5 - - Google Patents

Download PDF

Info

Publication number
JP2011139704A5
JP2011139704A5 JP2011019668A JP2011019668A JP2011139704A5 JP 2011139704 A5 JP2011139704 A5 JP 2011139704A5 JP 2011019668 A JP2011019668 A JP 2011019668A JP 2011019668 A JP2011019668 A JP 2011019668A JP 2011139704 A5 JP2011139704 A5 JP 2011139704A5
Authority
JP
Japan
Prior art keywords
peptide
seq
composition
nucleic acid
isolated nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011019668A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011139704A (ja
JP5618852B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011139704A publication Critical patent/JP2011139704A/ja
Publication of JP2011139704A5 publication Critical patent/JP2011139704A5/ja
Application granted granted Critical
Publication of JP5618852B2 publication Critical patent/JP5618852B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2011019668A 2004-03-01 2011-02-01 天然IgM抗体およびその阻害剤 Expired - Fee Related JP5618852B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54912304P 2004-03-01 2004-03-01
US60/549,123 2004-03-01
US58864804P 2004-07-16 2004-07-16
US60/588,648 2004-07-16

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007501869A Division JP5557982B2 (ja) 2004-03-01 2005-03-01 天然IgM抗体およびその阻害剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014089965A Division JP2014155497A (ja) 2004-03-01 2014-04-24 天然IgM抗体およびその阻害剤

Publications (3)

Publication Number Publication Date
JP2011139704A JP2011139704A (ja) 2011-07-21
JP2011139704A5 true JP2011139704A5 (enExample) 2012-04-05
JP5618852B2 JP5618852B2 (ja) 2014-11-05

Family

ID=34922704

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007501869A Expired - Fee Related JP5557982B2 (ja) 2004-03-01 2005-03-01 天然IgM抗体およびその阻害剤
JP2011019668A Expired - Fee Related JP5618852B2 (ja) 2004-03-01 2011-02-01 天然IgM抗体およびその阻害剤
JP2014089965A Pending JP2014155497A (ja) 2004-03-01 2014-04-24 天然IgM抗体およびその阻害剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007501869A Expired - Fee Related JP5557982B2 (ja) 2004-03-01 2005-03-01 天然IgM抗体およびその阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014089965A Pending JP2014155497A (ja) 2004-03-01 2014-04-24 天然IgM抗体およびその阻害剤

Country Status (9)

Country Link
US (5) US7442783B2 (enExample)
EP (2) EP1725659B1 (enExample)
JP (3) JP5557982B2 (enExample)
AT (1) ATE498010T1 (enExample)
AU (1) AU2005219839B9 (enExample)
CA (1) CA2560066A1 (enExample)
DE (1) DE602005026260D1 (enExample)
IL (1) IL177825A (enExample)
WO (1) WO2005085288A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100136684A1 (en) * 2004-03-01 2010-06-03 Carroll Michael C Natural IgM Antibodies
AU2005219839B9 (en) * 2004-03-01 2011-12-22 Immune Disease Institute, Inc Natural IgM antibodies and inhibitors thereof
US8324352B2 (en) 2009-12-07 2012-12-04 Decimmune Therapeutics, Inc. Anti-inflammatory antibodies and uses therefor
AU2011261270A1 (en) * 2010-06-03 2012-12-13 Abraxis Bioscience, Llc Peripheral blood SPARC antibodies and uses thereof
WO2014055392A2 (en) * 2012-10-01 2014-04-10 Decimmune Therapeutics, Inc. Method of protecting cardiac function
HK1220207A1 (zh) 2013-03-12 2017-04-28 Decimmune Therapeutics Inc. 人源化抗n2抗体
JP6551825B2 (ja) * 2014-02-10 2019-07-31 公立大学法人首都大学東京 クロマチン構造制御剤

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
EP1541682A3 (en) 1988-09-02 2005-07-06 Dyax Corp. Generation and selection of recombinant varied binding proteins
WO1990002909A1 (en) 1988-09-06 1990-03-22 Asarco Incorporated Method and burner for melting copper
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5096815A (en) 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
US5198346A (en) 1989-01-06 1993-03-30 Protein Engineering Corp. Generation and selection of novel DNA-binding proteins and polypeptides
WO1991000906A1 (en) 1989-07-12 1991-01-24 Genetics Institute, Inc. Chimeric and transgenic animals capable of producing human antibodies
AU6886791A (en) 1989-11-13 1991-06-13 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
AU7163091A (en) * 1989-12-12 1991-07-18 Biomedical Research Institute Novel malarial sporozoite peptide antigens
ES2087997T3 (es) 1990-01-12 1996-08-01 Cell Genesys Inc Generacion de anticuerpos xenogenicos.
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
JPH06508511A (ja) 1990-07-10 1994-09-29 ケンブリッジ アンティボディー テクノロジー リミティド 特異的な結合ペアーの構成員の製造方法
WO1992003917A1 (en) 1990-08-29 1992-03-19 Genpharm International Homologous recombination in mammalian cells
ES2108048T3 (es) 1990-08-29 1997-12-16 Genpharm Int Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
DE69129154T2 (de) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
ES2155822T3 (es) 1990-12-06 2001-06-01 Affymetrix Inc Compuestos y su utilizacion en una estrategia de sintesis binaria.
DE69233769D1 (de) 1991-03-01 2009-09-24 Dyax Corp Chimäres Protein mit Mikroprotein mit zwei oder mehr Disulfidbindungen und Ausgestaltungen davon
ATE414768T1 (de) 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
DE69233087T2 (de) 1991-11-22 2003-12-24 Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) Verfahren zur Herstellung von Polymerarrays
US5233409A (en) 1992-02-25 1993-08-03 Schwab Karl W Color analysis of organic constituents in sedimentary rocks for thermal maturity
US5359115A (en) 1992-03-26 1994-10-25 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5288514A (en) 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
DE69333087T2 (de) 1992-10-01 2004-05-06 The Trustees Of Columbia University In The City Of New York Komplexe kombinatorische chemische banken, die mit markierungen versehen sind
US6174530B1 (en) 1993-05-05 2001-01-16 Gryphon Sciences Homogeneous polyoxime compositions and their preparation by parallel assembly
WO1994029351A2 (en) 1993-06-16 1994-12-22 Celltech Limited Antibodies
US5362899A (en) 1993-09-09 1994-11-08 Affymax Technologies, N.V. Chiral synthesis of alpha-aminophosponic acids
US6184344B1 (en) 1995-05-04 2001-02-06 The Scripps Research Institute Synthesis of proteins by native chemical ligation
US6376653B1 (en) 1998-09-28 2002-04-23 Smithkline Beecham Plc Tie2 antagonist antibodies
WO2001064835A2 (en) * 2000-02-28 2001-09-07 Hyseq, Inc. Novel nucleic acids and polypeptides
JP2002531107A (ja) * 1998-12-03 2002-09-24 フェージテック,インコーポレーテッド バクテリオファージゲノミクスに基づく新規抗微生物剤の開発
NZ512941A (en) 1999-01-15 2003-09-26 Us Agriculture Length polymorphisms in microsatellite (simple sequence repeat - SSR) DNA markers and their use as genetic markers in pine
US6753314B1 (en) * 1999-04-01 2004-06-22 Curagen Corporation Protein-protein complexes and methods of using same
US6355481B1 (en) * 1999-06-18 2002-03-12 Emory University Hybridoma cell line and monoclonal antibody for huntingtin protein
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
AU2001263006A1 (en) * 2000-05-18 2001-11-26 Hyseq, Inc. Novel nucleic acids and polypeptides
JP2004502412A (ja) * 2000-06-08 2004-01-29 ザ センター フォー ブラッド リサーチ インコーポレーティッド 免疫グロブリンを介した再灌流障害を抑制するための方法および組成物
US6534058B2 (en) * 2000-10-10 2003-03-18 Tanox, Inc. Anti-C5 monoclonal antibodies
WO2002096948A2 (en) * 2001-01-29 2002-12-05 Idec Pharmaceuticals Corporation Engineered tetravalent antibodies and methods of use
US20040131607A1 (en) 2001-06-08 2004-07-08 Carroll Michael C. Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury
WO2003055982A2 (en) * 2001-12-21 2003-07-10 Diadexus, Inc. Compositions and methods relating to endometrial specific genes and proteins
US20050123551A1 (en) * 2001-12-21 2005-06-09 Yongming Sun Compositions and methods relating to endometrial specific genes and proteins
US7709610B2 (en) * 2003-05-08 2010-05-04 Facet Biotech Corporation Therapeutic use of anti-CS1 antibodies
US20100136684A1 (en) 2004-03-01 2010-06-03 Carroll Michael C Natural IgM Antibodies
AU2005219839B9 (en) * 2004-03-01 2011-12-22 Immune Disease Institute, Inc Natural IgM antibodies and inhibitors thereof
US7612181B2 (en) * 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
IT1395574B1 (it) 2009-09-14 2012-10-16 Guala Dispensing Spa Dispositivo di erogazione

Similar Documents

Publication Publication Date Title
JP2011139704A5 (enExample)
JP2019522490A5 (enExample)
JP2012143232A5 (enExample)
JP2020018311A5 (enExample)
AR086360A1 (es) Polipeptidos anticuerpos que antagonizan cd40
FI3736291T3 (fi) Anti-fcrh5-vasta-aineita
JP2012527899A5 (enExample)
JP2014516540A5 (enExample)
JP2014528714A5 (enExample)
JP2013543384A5 (enExample)
JP2010511388A5 (enExample)
CN104086652B (zh) 抗o型口蹄疫病毒特异性单域抗体及其重组表达载体
JP2012518425A5 (enExample)
FI3378535T3 (fi) Alfa-synukleiinin tunnistavia humanisoituja vasta-aineita
JP2012116856A5 (enExample)
JP2017114866A5 (enExample)
JP2014518615A5 (enExample)
JP2013520426A5 (enExample)
JP2011062217A5 (enExample)
AR073978A1 (es) Anticuerpos humanos de alta afinidad para el receptor il-4-humano
JP2011182801A5 (enExample)
JP2007197439A5 (enExample)
JP2018532382A5 (enExample)
JP2010533498A5 (enExample)
JP2012095652A5 (enExample)